We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
In this recorded interview, Erik Vaessen, Chief Business Officer – Life Sciences, presents our latest innovation, Oceo Rover - the first and only Read more...
At FUJIFILM Irvine Scientific, we pride ourselves on providing unparalleled value to our customers. Our sales teams specialize in working closely with both Read more...
As MSCs become more popular in regenerative medicines and cell therapies, the ability to automate the manufacturing of MSC-based therapies efficiently is paramount Read more...
What is your role at FUJIFILM Irvine Scientific, and when did you join the Company?
I am currently the Environmental Health and Safety (EHS) Manager for Read more...
When did you join FUJIFILM Irvine Scientific, and what attracted you to the company?
I joined FUJIFILM Irvine Scientific in July 2019 as Director of Read more...
Achieving high cell densities in long-term cultures is often a challenge facing bioprocessing manufacturers, and one that requires the support of optimal media. Read more...
Our careful selection of raw materials and processes help to reduce risk
Regulatory agencies, including the Federal Drug Administration (FDA), the European Read more...
An Interview with R&D Scientist Catherine Nguyen on Benefit of Using a Media Survey Panel versus Media Screen Protocols
We recently sat down with Read more...
Q: What does Express Media mean and what makes it express?
A: Express Media Service (EMS) refers to our service program manufacturing and delivering small-scale, Read more...
Driving the Successful Development and Production of Combination Biotherapies
A presentation by Robert Newman, PhD, CSO, FUJIFILM Irvine Scientific
At the 2021 Read more...